New-onset diabetes in COVID-19 and clinical outcomes: A systematic review and meta-analysis

Table 1 JBI bias assessment for observational studies

Questions (Yes/No/Unclear/Not applicable)	Smith et al [19], 2021	Zhou et al [16], 2020	Wang et al [20], 2020	Fadini et al [17], 2020	Wang et al [21], 2020	Li et al[14], 2020
Were the two groups similar and recruited from the same population?	Yes	Yes	Yes	Yes	Yes	Yes
Were the exposures measured similarly to assign people to both exposed and unexposed groups?	Yes	Yes	Yes	Yes	Yes	Yes
Was the exposure measured in a valid and reliable way?	Yes	Yes	Yes	Yes	Yes	Yes
Were confounding factors identified?	Yes	Yes	Yes	Yes	Yes	Yes
Were strategies to deal with confounding factors stated?	Yes	No	No	Yes	No	Yes
Were the groups/participants free of the outcome at the start of the study (or at the moment of exposure)?	Yes	Yes	Yes	Yes	Yes	Yes
Were the outcomes measured in a valid and reliable way?	Yes	Yes	Yes	Yes	Yes	Yes
Was the follow-up time reported and sufficient to be long enough for outcomes to occur?	No	No	No	No	Yes	Yes
Was follow-up complete, and if not, were the reasons for loss to follow-up described and explored?	Yes	Yes	Yes	Yes	Yes	Yes
Were strategies to address incomplete follow-up utilized?	Not applicable	Not applicable	Not applicable	Not applicable	Not applicable	Yes
Was appropriate statistical analysis used?	Yes	Yes	Yes	Yes	Yes	Yes
Overall appraisal	Include	Include	Include	Include	Include	Include